Aker BioMarine

AKBM

NO0010886625

Fishing & Farming

Real-time Oslo Bors Other stock markets 09:47:07 2024-07-16 EDT			5-day change	1st Jan Change
93.4 ^NOK	+3.43%		+2.64%	+103.04%

07-12	Aker BioMarine AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
07-12	Aker BioMarine AS Expects to Pay Extraordinary Dividend	CI

Aker BioMarine Antarctic Holding II AS agreed to acquire Feed Ingredients business of Aker BioMarine AS (OB:AKBM).

July 02, 2024

Aker BioMarine Antarctic Holding II AS agreed to acquire Feed Ingredients business of Aker BioMarine AS (OB:AKBM) on July 3, 2024. The transaction is subject to subject to antitrust regulations. The transaction is expected to close during the third quarter of 2024.

Latest news about Aker BioMarine

Aker BioMarine AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	07-12	CI
Aker BioMarine AS Expects to Pay Extraordinary Dividend	07-12	CI
Transcript : Aker BioMarine AS, Q2 2024 Earnings Call, Jul 12, 2024	07-12
Aker BioMarine Antarctic Holding II AS completed the acquisition of Feed Ingredients business of Aker BioMarine AS (OB:AKBM).	07-08	CI
Aker BioMarine to Sell Feed Ingredients Unit	07-04	MT
Aker BioMarine Antarctic Holding II AS agreed to acquire Feed Ingredients business of Aker BioMarine AS (OB:AKBM).	07-02	CI
Aker BioMarine AS Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Transcript : Aker BioMarine AS, Q1 2024 Earnings Call, Apr 26, 2024	04-26
Aker BioMarine AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-14	CI
Aker BioMarine AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-14	CI
Transcript : Aker BioMarine AS, Q4 2023 Earnings Call, Feb 14, 2024	02-14
Aker BioMarine ASA Receives Purchase Order for Algae-Based Omega-3 Oils	12-08	CI
Aker BioMarine Wins $6 Million Order for Omega-3 Oils; Production Capacity Expansion Planned	12-08	MT
Aker BioMarine AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-01	CI
Transcript : Aker BioMarine AS, Q3 2023 Earnings Call, Nov 01, 2023	11-01
Aker BioMarine Gains Krill Assets from Acasti Pharma in $3.1 Million Settlement Deal	23-10-24	MT
Aker Biomarine Begins Krill Oil Sales in South Korea	23-09-25	MT
Aker Biomarine Announces Successful Launch of Superba Krill Oil in South Korea	23-09-25	CI
Aker BioMarine's Krill Oil Brand Wins Australian Nod for Two Health Claims	23-08-25	MT
Aker BioMarine Gains Regulatory Approval for US Commercial Launch of Dietary Supplement	23-08-10	MT
Aker BioMarine ASA Receives Approval for LYSOVETA as New Dietary Suppient in the US	23-08-09	CI
Aker BioMarine AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-14	CI
Transcript : Aker BioMarine AS, Q2 2023 Earnings Call, Jul 14, 2023	23-07-14
Aker BioMarine AS Provides Revenue Guidance for the Full Year of 2023	23-07-13	CI
Aker BioMarine AS Announces Intention to Change Group Financial Reporting and Legal Entity Structure	23-06-29	CI

Chart Aker BioMarine

Duration

Period

More charts

Company Profile

Aker Biomarine ASA is a Norway-based biotech innovator and Antarctic krill-harvesting company. It consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarineâs focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.

Sector

Fishing & Farming

Calendar

2024-11-01 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Aker BioMarine

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

8.37 USD

Average target price

10.03 USD

Spread / Average Target

+19.83%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Fishing & Farming

	1st Jan change	Capi.
AKER BIOMARINE	+103.04%	734M
WENS FOODSTUFF GROUP CO., LTD.	+0.95%	18.57B
QL RESOURCES	+16.99%	3.48B
GODREJ AGROVET LIMITED	+53.53%	1.99B
SLC AGRÍCOLA S.A.	+0.90%	1.53B
CHERKIZOVO GROUP	-.--%	1.27B
SILDARVINNSLAN HF.	-12.02%	1.23B
DOLE PLC	+6.02%	1.23B
B.F. S.P.A.	+4.56%	1.2B
PT FAP AGRI TBK	0.00%	1.19B

Other Fishing & Farming

Aker BioMarine

Equities

AKBM

NO0010886625

Fishing & Farming

Aker BioMarine Antarctic Holding II AS agreed to acquire Feed Ingredients business of Aker BioMarine AS (OB:AKBM).

EPS Revisions